International Immunology Advance Access originally published online on April 18, 2005
International Immunology 2005 17(6):705-712; doi:10.1093/intimm/dxh250
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-ß
1 Department of Immunology, 2 Department of Otorhinolaryngology, Head and Neck Surgery and 3 Department of Dermatology, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Tamaho, Yamanashi 409-3898, Japan
4 Atopy Research Center and 5 Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan
Correspondence to: A. Nakao; E-mail: anakao{at}yamanashi.ac.jp
Some epidemiological or association studies suggest that transforming growth factor-ß (TGF-ß) in breast milk may be a decisive factor in diminishing the risk of allergic diseases during infancy. The observations have prompted us to investigate whether TGF-ß, when taken orally, can affect allergic immune responses. Repeated high-dose ovalbumin peptide (OVA) feeding was previously reported to induce OVA-specific IgE production and an anaphylactic reaction after intravenous challenge of OVA in OVA-TCR transgenic mice, which might represent a model for food allergy. By using this model, we showed here that oral administration of high-dose TGF-ß simultaneously with OVA feeding significantly inhibited the OVA-specific IgE elevation and anaphylactic reaction in OVA-TCR transgenic DO11.10 mice. These effects were associated with suppression of OVA-specific IL-4 production and GATA-3 expression and with up-regulation of IFN-
production and T-bet expression by splenocytes. Intra-peritoneal injection of anti-TGF-ß-neutralizing antibody abolished the inhibitory effects of orally administered TGF-ß on the serum IgE response and anaphylactic reaction after OVA feeding in DO11.10 mice. Interestingly, oral administration of high-dose TGF-ß suppressed activation-induced T cell death induced by OVA feeding in DO11.10 mice. We thus conclude that TGF-ß, when taken orally at high dose, has the capacity to modulate a food allergy-related reaction, at least in part, through its systemic activity.
Keywords: food allergy, IgE, Th2
Transmitting editor: H. Karasuyama
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. P. RamachandraRao, Y. Zhu, T. Ravasi, T. A. McGowan, I. Toh, S. R. Dunn, S. Okada, M. A. Shaw, and K. Sharma Pirfenidone Is Renoprotective in Diabetic Kidney Disease J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1765 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakamura, M. Miyata, T. Ando, N. Shimokawa, Y. Ohnuma, R. Katoh, H. Ogawa, K. Okumura, and A. Nakao The Latent Form of Transforming Growth Factor-{beta} Administered Orally Is Activated by Gastric Acid in Mice J. Nutr., August 1, 2009; 139(8): 1463 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ozawa, M. Miyata, M. Nishimura, T. Ando, Y. Ouyang, T. Ohba, N. Shimokawa, Y. Ohnuma, R. Katoh, H. Ogawa, et al. Transforming Growth Factor-{beta} Activity in Commercially Available Pasteurized Cow Milk Provides Protection against Inflammation in Mice J. Nutr., January 1, 2009; 139(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|